Plain-English translation of NCT04150198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying two different forms of early-onset Alzheimer's disease to understand how and why they affect people differently. Using advanced brain imaging (PET and MRI scans), they will look at brain structure, function, and protein markers in patients with typical memory-focused Alzheimer's versus those with vision and spatial problems. This research has no medication being tested; instead, it aims to discover the brain's own resilience mechanisms that allow some patients to cope better with the disease.
Alzheimer's disease affects different people in very different ways, even when they have the same underlying disease. By understanding what makes some brains more resilient to damage, researchers hope to eventually develop better treatments and predict which therapies will work best for individual patients.
You likely qualify if…
You likely don't qualify if…
You would come in for brain imaging visits using two types of scanners: PET and MRI, which take pictures of your brain's structure and activity. Before imaging, you'll have a blood test to make sure your kidneys and liver are working well enough for the procedure. You'll also likely complete memory and thinking tests to assess your cognitive abilities. The study enrolls 45 people total (15 with typical Alzheimer's, 15 with the vision-focused variant, and 15 healthy controls), and visits would occur at a French research center.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France